LONDON: Diaceutics PLC (AIM: DXRX), a leading technology and solutions provider for the pharma and biotech industry, has announced significant progress in expanding its US commercial activities. The company executed a commercial data partnership agreement in the first half of 2024 and four additional agreements in the second half, totaling £1.13 million ($1.48 million) in…